JPH06169983A - 医療用具 - Google Patents
医療用具Info
- Publication number
- JPH06169983A JPH06169983A JP5163483A JP16348393A JPH06169983A JP H06169983 A JPH06169983 A JP H06169983A JP 5163483 A JP5163483 A JP 5163483A JP 16348393 A JP16348393 A JP 16348393A JP H06169983 A JPH06169983 A JP H06169983A
- Authority
- JP
- Japan
- Prior art keywords
- acetylsalicylic acid
- medical device
- esterified
- ester
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960001138 acetylsalicylic acid Drugs 0.000 claims abstract description 28
- 150000002148 esters Chemical class 0.000 claims abstract description 19
- 229920000642 polymer Polymers 0.000 claims abstract description 12
- -1 acetylsalicylic acid ester Chemical class 0.000 claims abstract description 9
- 210000004369 blood Anatomy 0.000 claims abstract description 8
- 239000008280 blood Substances 0.000 claims abstract description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 6
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical compound CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 3
- 230000002708 enhancing effect Effects 0.000 claims abstract description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims abstract description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 23
- 239000000126 substance Substances 0.000 claims description 12
- 239000000654 additive Substances 0.000 claims description 10
- 239000004014 plasticizer Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 5
- 125000003368 amide group Chemical group 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 125000005273 2-acetoxybenzoic acid group Chemical group 0.000 claims 1
- 238000007493 shaping process Methods 0.000 claims 1
- 230000032050 esterification Effects 0.000 abstract description 3
- 238000005886 esterification reaction Methods 0.000 abstract description 3
- 150000002191 fatty alcohols Chemical class 0.000 abstract description 3
- 206010018910 Haemolysis Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000008588 hemolysis Effects 0.000 abstract 1
- 238000000576 coating method Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 229960002897 heparin Drugs 0.000 description 4
- 229920000669 heparin Polymers 0.000 description 4
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 239000011265 semifinished product Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000004610 Internal Lubricant Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229920000151 polyglycol Polymers 0.000 description 2
- 239000010695 polyglycol Substances 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- KGLVYIGKGJTMAF-UHFFFAOYSA-N 2,3-bis[(2-acetyloxybenzoyl)oxy]propyl 2-acetyloxybenzoate Chemical compound CC(=O)OC1=CC=CC=C1C(=O)OCC(OC(=O)C=1C(=CC=CC=1)OC(C)=O)COC(=O)C1=CC=CC=C1OC(C)=O KGLVYIGKGJTMAF-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- IHBCFWWEZXPPLG-UHFFFAOYSA-N [Ca].[Zn] Chemical compound [Ca].[Zn] IHBCFWWEZXPPLG-UHFFFAOYSA-N 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0052—Plasticizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
- A61L33/0041—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate characterised by the choice of an antithrombatic agent other than heparin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/10—Esters; Ether-esters
- C08K5/101—Esters; Ether-esters of monocarboxylic acids
- C08K5/103—Esters; Ether-esters of monocarboxylic acids with polyalcohols
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/10—Esters; Ether-esters
- C08K5/101—Esters; Ether-esters of monocarboxylic acids
- C08K5/105—Esters; Ether-esters of monocarboxylic acids with phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4221665A DE4221665C1 (enExample) | 1992-07-02 | 1992-07-02 | |
| DE4221665.6 | 1992-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH06169983A true JPH06169983A (ja) | 1994-06-21 |
Family
ID=6462283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5163483A Pending JPH06169983A (ja) | 1992-07-02 | 1993-07-01 | 医療用具 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0576868B1 (enExample) |
| JP (1) | JPH06169983A (enExample) |
| AT (1) | ATE191350T1 (enExample) |
| DE (1) | DE4221665C1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4341628C2 (de) * | 1993-12-07 | 1996-05-30 | Rehau Ag & Co | Verfahren zur Herstellung von medizinischen Arbeitsmitteln |
| DE19638570A1 (de) * | 1996-09-20 | 1998-03-26 | Bayer Ag | Wirkstoffhaltige thermoplastische Polyurethane |
| DE60322681D1 (de) | 2002-03-20 | 2008-09-18 | Gambro Lundia Ab | Extrakorporaler Kreislauf mit Schlauch für medizinische Anwendungen |
| DE102011076833A1 (de) * | 2011-05-31 | 2012-12-06 | Atmos Medizintechnik Gmbh & Co. Kg | Wunddrainageverfahren |
| CN105017515A (zh) * | 2015-07-20 | 2015-11-04 | 湖南华腾制药有限公司 | 聚乙二醇修饰物的制备方法 |
| CN105017519A (zh) * | 2015-07-20 | 2015-11-04 | 湖南华腾制药有限公司 | 一种聚乙二醇修饰的小分子药物的制备方法 |
| CN110668947B (zh) * | 2019-10-14 | 2021-05-18 | 新乡海盈生物科技有限责任公司 | 一种邻羟基苯甲酸聚二醇酯类化合物及其合成制备方法和医药用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH428766A (de) * | 1963-01-17 | 1967-01-31 | Yoshitomi Pharmaceutical | Verfahren zur Herstellung eines Esters der Acetylsalicylsäure mit einem mehrwertigen Alkohol |
| IT1085524B (it) * | 1977-03-22 | 1985-05-28 | Snam Progetti | Materiali e fibre porose biocompatibili in grado di inglobare sostanze di interesse biologico e metodi per il loro ottenimento |
| JPS6076562A (ja) * | 1983-10-03 | 1985-05-01 | Sumitomo Electric Ind Ltd | 抗血栓性樹脂組成物 |
| US5082925A (en) * | 1990-08-16 | 1992-01-21 | Ethicon, Inc. | Homopolymers and copolymers of salicylate lactones |
-
1992
- 1992-07-02 DE DE4221665A patent/DE4221665C1/de not_active Expired - Fee Related
-
1993
- 1993-06-05 EP EP93109084A patent/EP0576868B1/de not_active Expired - Lifetime
- 1993-06-05 AT AT93109084T patent/ATE191350T1/de not_active IP Right Cessation
- 1993-07-01 JP JP5163483A patent/JPH06169983A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0576868B1 (de) | 2000-04-05 |
| ATE191350T1 (de) | 2000-04-15 |
| DE4221665C1 (enExample) | 1993-08-12 |
| EP0576868A1 (de) | 1994-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0439908B1 (en) | Lubricous coatings, medical articles containing same and method for their preparation | |
| JP3253082B2 (ja) | 微生物付着の減少法 | |
| US3941858A (en) | Hydrophilic polymers, articles and methods of making same | |
| JPH06169983A (ja) | 医療用具 | |
| JP2002543885A (ja) | 抗閉塞剤を含む医療装置用の潤滑性コーティング | |
| JP2013530020A (ja) | 生体活性剤を送達する医療デバイスのための脂質コーティング | |
| WO1997014448A1 (en) | Biocompatible lubricious hydrophilic materials for medical devices | |
| CN101962461B (zh) | 不含邻苯二甲酸酯的医用聚氯乙烯塑料 | |
| JP3522839B2 (ja) | 湿潤時に表面が潤滑性を有する医療用具及びその製造方法 | |
| JPH02261470A (ja) | カテーテル先端形成間のダイ脱離方法 | |
| JPH05137778A (ja) | 医療器具 | |
| ES2865503T3 (es) | Catéteres urinarios lubricados que tienen flexibilidad variable | |
| CN1041424C (zh) | 用于聚氯乙烯配方的添加剂体系 | |
| JPH07289630A (ja) | 抗血栓性塗料、およびこれを塗布した医療、生理衛生用品 | |
| KR102309875B1 (ko) | 카테터 내측 튜브용 수지 조성물 및 이를 이용한 내측 튜브 | |
| JPS5933343A (ja) | 塩化ビニル樹脂組成物 | |
| US3761286A (en) | Chewing gum composition containing flavored homopolymers | |
| JPS60115640A (ja) | 生医学用のプラスチツク組成物用の可塑剤、それを含有するプラスチツク組成物及び該組成物で製造された生医学用物品 | |
| BR0013688A (pt) | Métodos para a fabricação de uma tubulação médica e de uso de uma tubulação médica com uma bomba para a administração de quantidades dosadas de um fluido benéfico ao longo do tempo a um paciente, e, tubulação | |
| JPS587298B2 (ja) | 親水性表面を有するビニルエステル系合成樹脂からなる医療用成形物の製造法 | |
| JPH027668B2 (enExample) | ||
| JP5957912B2 (ja) | 眼内レンズ挿入器具の処理方法 | |
| KR100490272B1 (ko) | 그래프트 중합체 및 이를 사용한 의료용 성형품 | |
| JPS6023621B2 (ja) | 医療具用塩化ビニル樹脂組成物 | |
| JPH06169995A (ja) | 血管拡張用カテーテルバルーン |